期刊文献+

肺炎链球菌不同菌株自溶酶基因的克隆、序列分析及重组表达 被引量:5

Cloning, sequence analysis and expressing of LytA gene from different strains of Streptococcus pneumoniae
原文传递
导出
摘要 目的克隆肺炎链球菌自溶酶(LytA)的基因序列,并进行重组表达。方法分别提取不同临床分离株的基因组DNA,根据已知肺炎链球菌野生R6株LytA基因序列设计引物,进行PCR扩增,将获得的目的基因片段克隆入原核表达质粒,然后测序;利用生物信息学方法,对不同临床分离株LytA基因序列进行比较分析,同时进行LytA基因的重组表达。结果从不同临床分离株的基因组中均扩增出完整的LytA基因片段,成功构建了重组质粒pGEX-4T-1-L-ytA。比较不同临床分离株LytA基因的DNA序列及推测的氨基酸序列,发现各株LytA基因序列及氨基酸序列间存在差异。通过异丙基巯基半乳糖(IPTG)诱导,LytA基因在大肠埃希菌JM109中得到高效表达,十二烷基硫酸钠聚丙烯酰胺凝胶电泳(SDSPAGE)结果显示pGEX-4T-1-L-ytA融合蛋白相对分子质量约62000,与理论预测一致。结论序列分析发现各分离株的LytA基因序列及氨基酸序列间存在差异,但同源性极高,推测LytA基因序列保守,可用于疫苗研发。 Objective To clone the gene of autolysin(LytA) which are from different clinical strains of Streptococcus pneumoniae and express them in Escherichia coli. Methods The LytA gene was amplified by PCR from the total DNA of S.pneumoniae. Primers were designed according to the LytA gene sequence of R6. Recombinant plasmids were constructed and the sequences of different clinical strains were analyzed through method of bioinformatics. The cloned genes were expressed in E.coli and detected by SDS-PAGE. Results Complete LytA gene were amplified from all of the different clinical strains of S.pneumoniae and recombinant plasmids pGEX-4T-1-LytA were constructed successfully. After comparing the sequence of DNA and supposed protein, we find some differences. Induced by IPTG, LytA gene was expressed effectively in E.coli Jm109. Result of SDS-PAGE showed that the molecular weight of expressed protein was 62 kD, the same as calculated. Conclusions The sequences encoding LytA from different clinical strains of S.pneumoniae were cloned, the recombinant plasmids pGEX-4T-1-LytA was constructed successfully. Sequence analysis showed that there have difference among the gene and amino acid sequences of LytA from different clinical strains. Further studies should be focused on whether the difference contributes to activity of autolysin and the drug-resistance of S.pneumoniae.
出处 《中华传染病杂志》 CAS CSCD 北大核心 2005年第2期87-90,共4页 Chinese Journal of Infectious Diseases
  • 相关文献

参考文献13

  • 1Garcia P, Garcia JL, Garcia E, et al. Nucleotide sequence and expression of the pneumococcal autolysin gene from its own promoter in Escherichia coll. Gene, 1986, 43:265-272.
  • 2Jedrzejas MJ. Pneumococcal virulence factors: structure and function. Microbiol Mol Biol Rev, 2001, 65 : 187-207.
  • 3F.奥斯伯 R.布伦特 等.精编分子生物学实验指南[M].北京:科学出版社,2001..
  • 4J.萨姆布鲁克 E.F.弗里奇 T.曼尼阿蒂斯 著.金冬雁 黎孟枫 译.侯云德 校.分子克隆实验指南.第2版[M].北京:科学出版社,2002.881-885.
  • 5Briese T. Hakenbeck R. Interaction of the pneumococcal amidase with lipoteichoic acid and choline. Eur J Biochem, 1985,146:417-427.
  • 6Berry AM, Lock RA, Hansman D, et al. Contribution of autolysin to virulence of streptococcus pneumoniae. Infect Immun, 1989, 57: 2324-2330.
  • 7Berry AM, Paton JC. Additive attenuation of virulence of Streptococcus pneumoniae by mutation of genes encoding pneumolysin and other putative pneumococcal virulence proteins. Infect Immun, 2000, 68:133-140.
  • 8Tomasz A, Albino A, Zanati E. Multiple antibiotic resistance in a bacterium with suppressed autolytic system. Nature,1970, 227: 138-140.
  • 9Liu HH, Tomasz A. Penicillin tolerance in multiply drug-resistant natural isolates of streptococcus pneumoniae. J Infect Dis, 1985, 152: 365-372.
  • 10Sanchez-puelles JM, Ronda C, Garcia JI., et al. Searching for autolysin functions characterization of a pneumococcal mutant deleted in the LytA gene. Eur J Biochem, 1986, 158: 289-296.

共引文献1

同被引文献67

  • 1Butler JC, Breiman RF, Campbell JF, et al. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations. JAMA,1993, 270(15) : 1826-1831.
  • 2Kadioglu A, Andrew PW. The innate immune response to pneumococcal lung infection: the untold story. Trends Immunol, 2004, 25(3 ) : 143-149.
  • 3Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med, 2001,344(6) : 403-409.
  • 4Spoulou V, Gilks CF, Ioannidis JP. Protein conjugate pneumococcal vaccines. BMJ, 2002, 324(7340) : 750-751.
  • 5Kayhty H, Eskola J. New vaccines for the prevention of pneumococcal infections. Emerg Infect Dis, 1996, 2(4) : 289-299.
  • 6Briles DE, Hollingshead SK, Crain M J, et al. Pneumococcal proteins that may constitute the next generation vaccine for pneumococcal disease. International Congress Series, 2003, 1257 (2003) : 27-31.
  • 7Fernandez-Tornero C, Garcia E, Lopez R, et al. Two new crystal forms of the choline-binding domain of the major pneumococcal autolysin: insights into the dynamics of the active homodimer. J Mol Biol, 2002, 321(1): 163-173
  • 8Bogaert D, Hermans PW, Adrian PV, et al. Pneumococcal vaccines; an update on current strategies. Vaccine, 2004, 22 (17- 18) : 2209-2220.
  • 9Swiatlo E, Ware D. Novel vaccine strategies with protein antigens of Streptococcus pneumoniae. FEMS Immunol Med Microbiol, 2003, 38(1) : 1-7.
  • 10Poland GA. The burden of pneumococcal disease : the role of conjugate vaccines. Vaccine, 1999, 17 (13-14) : 1674-1679.

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部